KR20020078709A - Composition for treating a acne vulgaris and method for fabricating the same - Google Patents

Composition for treating a acne vulgaris and method for fabricating the same Download PDF

Info

Publication number
KR20020078709A
KR20020078709A KR1020010018830A KR20010018830A KR20020078709A KR 20020078709 A KR20020078709 A KR 20020078709A KR 1020010018830 A KR1020010018830 A KR 1020010018830A KR 20010018830 A KR20010018830 A KR 20010018830A KR 20020078709 A KR20020078709 A KR 20020078709A
Authority
KR
South Korea
Prior art keywords
weight
extract
parts
acne
composition
Prior art date
Application number
KR1020010018830A
Other languages
Korean (ko)
Inventor
안일호
김종인
권성원
Original Assignee
(주) 바임래버러토리즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 바임래버러토리즈 filed Critical (주) 바임래버러토리즈
Priority to KR1020010018830A priority Critical patent/KR20020078709A/en
Priority to PCT/KR2001/001740 priority patent/WO2002076479A1/en
Priority to US10/473,044 priority patent/US20040101577A1/en
Publication of KR20020078709A publication Critical patent/KR20020078709A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A process of preparing a composition for treating acne by extracting Chinese herbal medicine such as Glycyrrhizae Radix, Phellodendri Cortex, etc. is provided. Whereby, the composition has a keratosis and sebum-secretion inhibiting function as well as a dermatitis and acne bacteria removing function. CONSTITUTION: About 0.01 to 20 parts by weight of a herbal extract such as a burdock extract, 0.1 to 20 parts by weight of a Glycyrrhizae Radix extract and 0.1 to 20 parts by weight of Phellodendri Cortex are mixed with a specified amount of purified water followed by 1 to 50 parts by weight of alcohol and 0.001 to 1 part by weight of salicylic acid and then extracted.

Description

여드름 치료용 조성물 및 그 제조방법{Composition for treating a acne vulgaris and method for fabricating the same}Composition for treating a acne and method for manufacturing the same {Composition for treating a acne vulgaris and method for fabricating the same}

본 발명은 피부질환, 예컨대, 여드름 치료용 조성물에 관한 것으로, 좀더 상세하게는 "염증/세균" 뿐만 아니라, 여드름 발생의 주요기전으로 밝혀진 다른 각 원인들까지도 일괄적으로 대응·치료할 수 있는 여드름 치료용 조성물에 관한 것이다. 더욱이, 본 발명은 이러한 여드름 치료용 조성물을 제조하기 위한 제조방법에 관한 것이다.The present invention relates to a composition for treating skin diseases, such as acne, and more particularly, "acne / bacteria", as well as acne treatment that can cope with and treat each other cause identified as the main mechanism of acne. It relates to a composition for. Moreover, the present invention relates to a manufacturing method for producing a composition for treating acne.

최근, 피부미용에 대한 관심이 급증하면서, 피부질환, 예컨대, 여드름(Acne vulgaris)에 대한 다양한 연구들이 진행되고 있다.Recently, as the interest in skin care is rapidly increasing, various studies on skin diseases such as acne (Acne vulgaris) have been conducted.

이와 같은 종래, 연구들의 일례로, 미국특허공보 제 5019567 호 "벤조일 퍼옥사이드, 사차 암모늄, 친유성 살리실산으로 구성된 의약제 및 화장 조성물 그리고 이들을 이용한 여드름 치료법(Benzoyl peroxide quaternary ammonium lipophilic salicylate based pharmaceutical and cosmetic compositions and their use especially in treatment of acne)"에는 예컨대, "벤조일 퍼 옥사이드의 항균작용을 통해 여드름을 치료할 수 있다"는 사실이 개시되어 있으며, 미국특허공보 제 5554654 호 "항 여드름제의 치료효과 강화방법(Method for enhancing the therapeutic effect of an anti-acne agent)"에는 예컨대, "기존의 주름방지성분인 하이드록시카복실 산(Hydroxycarboxylic acids)을 통해 여드름을 치료할 수 있다"는 사실이 개시되어 있다.As an example of such conventional studies, US Pat. No. 5019567, "Pharmaceutical and cosmetic compositions consisting of benzoyl peroxide, quaternary ammonium, lipophilic salicylic acid, and Benzoyl peroxide quaternary ammonium lipophilic salicylate based pharmaceutical and cosmetic compositions and their use especially in treatment of acne), for example, "can be treated acne through the antibacterial action of benzoyl peroxide", US Patent Publication No. 5554654 "Method of enhancing the therapeutic effect of anti-acne (Method for enhancing the therapeutic effect of an anti-acne agent) discloses, for example, that acne can be cured through the existing anti-wrinkle component, hydroxycarboxylic acids.

다른 예로, 미국특허공보 제 5621006 호 "벤질릭 산을 이용한 여드름 치료방법(Method for treating acne using benzilic acid)"에는 예컨대, "벤질릭 산을 사용하여 여드름을 치료할 수 있다"는 사실이 개시되어 있으며, 미국특허공보 제 5690946 호 "열 용천수 또는 미네랄 함유수를 포함하는 피부화장 조성물 및 여드름·노화 방지를 위한 활성화제(Cosmetic and/or dermatological composition containing thermal spring water or mineral water and combat acne or aging)", 미국특허공보 제 5997885 호 "열 용천수 또는 미네랄 함유수를 포함하는 피부화장 조성물 및 여드름·노화 방지를 위한 활성화제(Cosmetic and/or dermatological composition containing thermal spring water or mineral water and combat acne or aging)" 등에는 "온천수에 의해 여드름을 치료할 수 있다"는 사실이 개시되어 있다.As another example, U.S. Patent No. 5621006, "Method for treating acne using benzilic acid," discloses, for example, that "acne can be treated using benzylic acid." , U.S. Patent No. 5690946, "Cosmetic and / or dermatological composition containing thermal spring water or mineral water and combat acne or aging" , US Patent No. 5997885 "Cosmetic and / or dermatological composition containing thermal spring water or mineral water and combat acne or aging" The back discloses that "acne can be cured by hot water."

또 다른 예로, 미국특허공보 제 5961993 호 "비광촉매 금속 산화물 및 토코페롤을 포함한 조성물 및 이를 이용한 여드름 치료방법(Composition containing a non-photocatalytic metal oxide and tocopherol its use in the treatment of acne)"에는 "토코페롤 및 산화금속을 사용하여 여드름을 치료할 수 있다"는 사실이 개시되어 있으며, 미국특허공보 제 6168798 호 "여드름 및 기타 피부상태를 치료하기 위한 항 염증 조성물(Non-irritating composition for treating acne and other skin conditions)"에는 "항염·항균에 유효한 성분들을 이용하여 여드름을 치료할 수 있다"는 사실이 개시되어 있다.In another example, U.S. Patent No. 5961993 "Composition containing a non-photocatalytic metal oxide and tocopherol its use in the treatment of acne" includes "tocopherol and Metal oxides can be used to treat acne, US Patent Publication No. 6168798 "Non-irritating composition for treating acne and other skin conditions." "It is possible to cure acne by using ingredients effective for anti-inflammatory and antibacterial" is disclosed.

또 다른 예로, 미국특허공보 제 5248503 호 "허브 보충 식(Herbal dietary supplement)", 미국특허공보 제 5869540 호 "피부개선용 허브 취급방법(Herbal treatments for improving skin appearance)" 등에는 예컨대, 허브(Herb)를 이용하여, 여드름을 치료할 수 있다"는 사실이 개시되어 있으며, 미국특허공보 제 5716800 호 "복령 추출물을 함유한 항 여드름 조성물(Anti-acne composition containing a poria cocos wolf extract)", 미국특허공보 제 6183747 호 "덩굴여지 식물 추출물을 사용한 여드름 산 치료방법(Use of plant momordica charactia extracts for treatment of acne acid)" 등에는 예컨대, 식물 추출물을 사용하여 여드름을 치료할 수 있다"는 사실이 개시되어 있다.As another example, U.S. Patent No. 5248503 "Herbal dietary supplement" and U.S. Patent No. 5869540 "Herbal treatments for improving skin appearance", for example, such as herbs (Herb) Can be used to treat acne. ”US Patent Publication No. 5716800“ Anti-acne composition containing a poria cocos wolf extract ”, US Patent Publication. US Pat. No. 6,183,747, "Use of plant momordica charactia extracts for treatment of acne acid," and the like, for example, can be used to treat acne.

최근, 여드름에 대한 연구가 급진전하면서, 예컨대, "피부의 염증", "박테리아 등의 여드름균", "피부의 이상각화", "피지의 과잉분비" 등과 같은 여러 요인이 "여드름 발생"의 주요 기전(Mechanism)으로 작용한다는 사실이 밝혀졌다.In recent years, as research on acne has progressed rapidly, various factors, such as "inflammation of the skin", "acne bacteria such as bacteria", "skin abnormality", "excess of sebum", etc., are the main causes of acne. It turns out that it acts as a mechanism.

즉, 여드름은 단지, 어느 하나의 원인만으로 발생하는 "단순한 피부질병"이 아니라, 상술한 각 원인들 각각의 상호작용에 의해 발생하는 "복합적인 피부질병"이라는 사실이 밝혀진 것이다.That is, it has been found that acne is not a "simple skin disease" caused by only one cause, but a "complex skin disease" caused by the interaction of each of the above-mentioned causes.

그러나, 이러한 상황에도 불구하고, 앞서 언급한 종래의 기술들, 즉, 5019567 특허, 5554654 특허, 5621006 특허, 5690946 특허, 5997885 특허, 5961993특허, 5248503 특허, 5869540 특허, 5716800 특허, 6183747 특허 등은 단지, 여드름의 특정 발병기전, 예컨대, 함염, 항균 등을 타겟(Target)으로 하는 기술적인 사상만을 제시하고 있는데 그치고 있기 때문에, 현실적으로, 위에서 언급한 종래의 여러 기술들을 사용하는 것만으로, 만족할 만한 여드름 치료효과를 획득하는 데에는 아직 많은 한계가 따를 수밖에 없다. 특히, 6168798 특허에서 제시한 항 염증 조성물의 경우, 피부에 불필요한 자극을 주는 심각한 부작용을 수반하기 때문에, 이를 여드름 치료에 직접 활용하는 데에는 실질적으로 많은 문제점이 발생할 수밖에 없다.However, in spite of this situation, the above-mentioned conventional techniques, namely, the 5019567 patent, 5554654 patent, 5621006 patent, 5690946 patent, 5997885 patent, 5961993 patent, 5248503 patent, 5869540 patent, 5716800 patent, 6183747 patent, etc. However, since only the technical idea of targeting a specific pathogenesis of acne, for example, salt and antibacterial, is presented, in reality, only by using the above-mentioned conventional techniques, satisfactory acne treatment There are still many limitations to achieving the effect. In particular, in the case of the anti-inflammatory composition disclosed in the 6168798 patent is accompanied by serious side effects that cause unnecessary irritation to the skin, there are practically a lot of problems in using this directly in the treatment of acne.

따라서, 본 발명의 목적은 예컨대, "염증/세균" 뿐만 아니라, 여드름 발생의 주요기전으로 밝혀진 다른 각 원인들까지도 일괄적으로 대응·치료할 수 있는 복합 조성물을 구현하고, 이를 통해, 최종 완성되는 여드름 치료용 제품이 예컨대, "피부염증 제거 기능", "여드름균 제거기능", "피부 이상각화 억제기능", "피지 과잉분비 억제기능" 등을 한꺼번에 보유할 수 있도록 유도하는데 있다.Accordingly, an object of the present invention is to realize a complex composition that can cope and treat not only "inflammation / bacteria", but also each of the other causes identified as the main mechanism of acne development, through which the final acne Therapeutic products are intended to induce, for example, "skin inflammation removal function", "acne bacteria removal function", "skin abnormality keratinocyte suppression function", "sebum oversecretion suppression function" and the like.

본 발명의 또 다른 목적들은 다음의 상세한 설명으로부터 보다 명확해질 것이다.Still other objects of the present invention will become more apparent from the following detailed description.

상기와 같은 목적을 달성하기 위하여 본 발명에서는 소정의 유효성분, 예컨대, 프레버(Flavor)가 함유된 허브추출물(Herbal extract) 0.01 내지 20 중량부, 감초추출물(Glycyrrhiza extract) 0.01 내지 20 중량부, 황백추출물(Phellodendronamurense extract) 0.01 내지 20 중량부 그리고, 살리실리산(Salicylic acid) 0.001 내지 1 중량부가 서로 혼합되어 형성된 여드름 치료용 조성물을 개시한다.In order to achieve the above object, in the present invention, a predetermined active ingredient, for example, 0.01 to 20 parts by weight of Herbal Extract (Flavor) containing, 0.01 to 20 parts by weight of Glycyrrhiza extract, Disclosed is a composition for treating acne formed by mixing 0.01 to 20 parts by weight of Phellodendronamurense extract and 0.001 to 1 parts by weight of salicylic acid.

이때, 바람직하게, 상술한 허브추출물로는 예컨대, 버독추출물(Burdock extract)이 사용된다.At this time, preferably, the above-described herbal extract, for example, Burdock extract (Burdock extract) is used.

이러한 구성을 갖는 본 발명의 피부질환 치료용 조성물에서, 먼저, 버독추출물은 "여드름 발생기전"의 어느 하나, 예컨대, "피부로부터 피지가 과잉 분비되는 현상"을 억제시키는 기능을 수행한다. 통상, 피지의 과잉분비 현상은 5-알파-리덕타아제(5-α-reductase)라는 특정 효소(Enzyme)가 피부의 피지선(Sebaceous gland)에 작용하여, 피지의 분비를 촉진시키기 때문에 발생하는 것으로 알려져 있는 바, 이때, 본 발명의 버독추출물은 자신에게 함유된 틴닌산 및 프레버를 이용하여, 5-알파-리덕타아제의 활성을 억제시킴으로써, 결국, 자신에게 부여된 "피지 과잉분비 억제기능"을 원활하게 수행할 수 있게 된다.In the composition for treating skin diseases of the present invention having such a configuration, first, the burdock extract performs a function of inhibiting any one of the "acne generating mechanism", for example, "a phenomenon in which the sebum is excessively secreted from the skin". In general, the excessive secretion of sebum occurs because a specific enzyme called 5-alpha-reductase acts on sebaceous gland of the skin and promotes sebum secretion. As is known, the verdok extract of the present invention inhibits the activity of 5-alpha-reductase by using the tinnic acid and the prever contained in itself, and thus, endows itself with "sebum oversecretion function. "Can be done smoothly.

이와 아울러, 상술한 버독추출물과 함께 혼합되는 본 발명의 감초추출물은 "여드름 발생기전"의 다른 어느 하나, 예컨대, "피부염증"을 제거하는 기능을 수행한다. 앞의 버독추출물이 이러한 "피부염증 제거기능"을 수행할 수 있는 이유는 "글리실리진산(Glycylrrhizin acid)"이라는 물질을 주성분으로 함유하고 있기 때문이다. 통상, 이 글리실리진산은 예컨대, 한국특허공개공보 제 2000-49485 호 "고순도 감초 정제물 제조방법", 한국특허공개공보 제 2001-10664 호 "진양 첩부제 조성물 및 경피투여시스템" 등에 제시된 바와 같이, 일련의 우수한 항염증 기능을 보유하고 있다고 알려져 있는 바, 본 발명에서는 이 글리실리진산을 주성분으로 함유한감초추출물을 새롭게 응용하여, 앞의 버독추출물과 함께, 여드름 치료용 조성물로 복합·혼합함으로써, 본 발명에 의해 최종 완성되는 조성물이 앞의 "피지 과잉분비 억제기능"과 함께, 우수한 "피부염증 제거기능"을 동시에 보유할 수 있도록 유도하게 된다.In addition, the licorice extract of the present invention, which is mixed with the above-mentioned burdock extract, performs a function of removing any one of the "acne generating mechanism", for example, "skin inflammation". The reason that the previous Burdock extract can perform this "skin inflammation removal function" is because it contains a substance called "Glycylrrhizin acid" as a main ingredient. Usually, this glycylic acid is, for example, as disclosed in Korean Patent Publication No. 2000-49485, "Method of manufacturing high purity licorice purified water", Korean Patent Publication No. 2001-10664, "Jinyang patch composition and transdermal administration system". It is known that it has a series of excellent anti-inflammatory functions. In the present invention, a new application of licorice extract containing this glycylic acid as a main component is combined and mixed with the previous burdock extract in an acne treatment composition. In addition, the composition finally finished by the present invention will be induced to simultaneously retain the excellent "skin inflammation removal function" with the "sebum oversecretion inhibiting function".

한편, 상술한 버독추출물, 감초추출물 등과 함께 혼합되는 본 발명의 황백추출물은 "여드름 발생기전"의 또 다른 어느 하나, 예컨대, "여드름균"을 제거하는 기능을 수행한다. 통상, 이 황백추출물은 예컨대, 한국특허공개공보 제 1999-75521 호 "주름개선효과가 있는 생약추출물을 함유하는 화장료", 한국특허공개공보 제 2001-10368 호 "피부용 피지조절 화장료 조성물", 한국특허공개공보 제 2001-18655 호 "대황 추출물을 함유하는 화장료 조성물" 등에 제시된 바와 같이, 우수한 "피부 적응성"을 보유함과 아울러, 미국특허공보 제 5080900 호 "개가시나무회 수액 추출물을 함유한 피부염증 치료제(Treatment of skin ulcers with an aqueous extract of oak bark ash)"에 제시된 바와 같이, 우수한 항균기능을 보유하고 있다고 알려져 있다고 알려져 있는 바, 본 발명에서는 이 황백추출물을 새롭게 응용하여, 앞서 언급한 버독추출물, 감초추출물 등과 함께, 여드름 치료용 조성물로 복합·혼합하고, 이를 통해, 예컨대, 피부의 모낭(Hair follicle)에 상주하는 여드름균의 제거를 촉진시킴으로써, 본 발명에 의해 최종 완성되는 조성물이 상술한 "피지 과잉분비 억제기능", "피부염증 제거기능" 등과 함께, 우수한 "여드름균 제거기능"을 동시에 보유할 수 있도록 유도하게 된다.On the other hand, the yellowish white extract of the present invention, which is mixed with the above-mentioned Burdock extract, licorice extract and the like performs another function of "acne generating mechanism", for example, "acne bacteria". Usually, the yellowish white extract is disclosed in, for example, Korean Patent Laid-Open Publication No. 1999-75521 "Cosmetic Containing Herbal Extracts with Wrinkle Improvement Effect", Korean Patent Laid-Open Publication No. 2001-10368 "Skin Control Cosmetic Composition for Skin", Korean Patent As disclosed in Japanese Patent Application Laid-Open No. 2001-18655, "Cosmetic Composition Containing Rhubarb Extract," and the like, it possesses excellent "skin adaptability" and US Patent Publication No. 5080900 "Dermatitis Containing Red Oak Sap Extract. As shown in "Treatment of skin ulcers with an aqueous extract of oak bark ash", it is known to possess excellent antibacterial function. In the present invention, the new application of the yellowish white extract, the aforementioned Burdock extract , With licorice extract, etc., are mixed and mixed into a composition for treating acne, and through this, for example, an eye that resides in a hair follicle of the skin By facilitating the removal of bacteria, the composition finalized by the present invention, together with the "sebum secretion inhibiting function", "skin inflammation removal function" and the like described above, to induce a good "acne bacteria removal function" at the same time do.

다른 한편, 상술한 버독추출물, 감초추출물, 황백추출물 등과 함께 혼합되는본 발명의 살리실리산은 "여드름 발생기전"의 또 다른 어느 하나, 예컨대, "피부의 이상각화"를 억제하는 기능을 수행한다. 통상, 이 살리실리산은 베타-하이드록시산(Beta-hydroxy acid)을 주성분으로 하면서, 예컨대, 한국특허공개공보 제 1998-43225 호 "항진균성 화장비누 조성물", 한국특허공개공보 제 2001-11241 호 "피부 보호용 크림조성물" 등에 제시된 바와 같이, 우수한 피부각질 연화기능, 피부주름 제거기능을 보유하고 있다고 알려져 있는 바, 본 발명에서는 이 살리실리산을 새롭게 응용하여, 앞서 언급한 버독추출물, 감초추출물, 황백추출물 등과 함께, 여드름 치료용 조성물로 복합·혼합함으로써, 본 발명에 의해 최종 완성되는 조성물이 상술한 "피지 과잉분비 억제기능", "피부염증 제거기능", "여드름균 제거기능" 등과 함께, 우수한 "피부 이상각화 억제기능"을 동시에 보유할 수 있도록 유도하게 된다.On the other hand, the salicylic acid of the present invention, which is mixed with the above-mentioned Burdock extract, licorice extract, yellowish white extract and the like performs another function of "acne generation mechanism", for example, "skin abnormality". Usually, this salicylic acid has a beta-hydroxy acid as a main component, for example, Korean Patent Publication No. 1998-43225 "Antifungal Cosmetic Soap Composition", Korean Patent Publication No. 2001-11241 As shown in the "protective cream composition for skin" and the like, it is known that it has excellent skin exfoliation function and wrinkle removal function. In the present invention, the salicylic acid is newly applied, and the aforementioned burdock extract, licorice extract, By combining and mixing with acne treatment composition, such as sulfur white extract, the composition finally finished by the present invention together with the "sebum secretion suppression function", "skin inflammation removal function", "acne bacteria removal function" and the like, It can be induced to simultaneously possess excellent "skin aberration suppression function".

요컨대, 본 발명에서는 상술한 버독추출물, 감초추출물, 황백추출물, 살리실리산 등을 적정량 혼합하여, "염증/세균" 뿐만 아니라, 여드름 발생의 주요기전으로 밝혀진 다른 각 원인들까지도 개별적으로 대응·치료할 수 있는 복합 조성물을 구현하고, 이를 통해, 최종 완성되는 여드름 치료용 제품이 예컨대, "피부염증 제거 기능", "여드름균 제거기능", "피부 이상각화 억제기능", "피지 과잉분비 억제기능" 등을 한꺼번에 보유할 수 있도록 유도할 수 있다.In short, in the present invention, by mixing an appropriate amount of the above-mentioned Burdock extract, licorice extract, yellowish white extract, salicylic acid and the like, not only "inflammatory / bacterial", but also each of the other causes identified as the main mechanism of acne can be treated individually To realize a complex composition, through which the final acne treatment product is, for example, "skin inflammation removal", "acne bacteria removal", "skin abnormal keratin suppression", "sebum oversecretion suppression" It can be induced to hold the back at once.

이하, 상술한 여드름 치료용 조성물을 제조하는 방법을 상세히 설명한다.Hereinafter, a method of preparing the aforementioned acne treatment composition will be described in detail.

본 발명에서는 먼저, 10 중량부의 정제수(Refined water)에 프레버가 함유된 버독추출물 0.01 내지 20 중량부와, 감초추출물 0.01 내지 20 중량부, 그리고, 황백추출물 0.01 내지 20 중량부를 혼합하는 과정을 진행한다.In the present invention, first, the process of mixing 0.01 to 20 parts by weight of Burdock extract containing 0.01 to 20 parts by weight of purified water (Refined water), 0.01 to 20 parts by weight of licorice extract, and 0.01 to 20 parts by weight of white and white extract do.

이때, 버독추출물의 함량이 0.01 중량부 미만인 경우, 허브 자체의 효과가 발휘되지 못하는 문제점이 야기될 수 있으며, 버독추출물의 함량이 20 중량부를 초과하는 경우, "최종 완성되는 제품의 향취가 너무 강해지는 문제점", "별다른 추가 효과 없이, 원자재만 낭비되는 문제점" 등이 야기될 수 있기 때문에, 본 발명에서는 이러한 문제점을 충분히 감안하여, 버독추출물의 함량을 앞서 언급한 "0.01 내지 20 중량부" 내에서 적절히 유지시킨다.At this time, if the content of the burdock extract is less than 0.01 parts by weight, it may cause a problem that the effect of the hub itself is not exhibited, if the content of the burdock extract exceeds 20 parts by weight, "the odor of the final product is too strong Problem "," the problem that only raw materials are wasted without additional effects "and the like, in view of the above problems in the present invention, the content of the Burdock extract in the aforementioned" 0.01 to 20 parts by weight " Maintain appropriately at.

또한, 감초추출물의 함량이 0.01 중량부 미만인 경우, 감초추출물 고유의 효과가 발휘되지 못하는 문제점이 야기될 수 있으며, 감초추출물의 함량이 20 중량부를 초과하는 경우, "최종 완성되는 제품의 향취가 너무 강해지는 문제점", "별다른 추가 효과 없이, 원자재만 낭비되는 문제점" 등이 야기될 수 있기 때문에, 본 발명에서는 이러한 문제점을 충분히 감안하여, 감초추출물의 함량을 앞서 언급한 "0.01 내지 20 중량부" 내에서 적절히 유지시킨다.In addition, if the content of licorice extract is less than 0.01 parts by weight, a problem that the intrinsic effect of licorice extract may not be exhibited, may cause a problem, if the content of licorice extract exceeds 20 parts by weight, "Fragrance of the final finished product is too Since the problem of becoming stronger "," a problem that only raw materials are wasted without any additional effects ", etc. can be caused, the present invention fully takes account of these problems, and the content of licorice extract is" 0.01 to 20 parts by weight ". Maintain appropriately within.

이와 아울러, 황백추출물의 함량이 0.01 중량부 미만인 경우, 황백추출물 고유의 효과가 발휘되지 못하는 문제점이 야기될 수 있으며, 황백추출물의 함량이 20 중량부를 초과하는 경우, 앞의 경우와 유사하게, "최종 완성되는 제품의 향취가 너무 강해지는 문제점", "별다른 추가 효과 없이, 원자재만 낭비되는 문제점" 등이 야기될 수 있기 때문에, 본 발명에서는 이러한 문제점을 충분히 감안하여, 황백추출물의 함량을 앞서 언급한 "0.01 내지 20 중량부" 내에서 적절히 유지시킨다.In addition, when the content of the yellow-white extract is less than 0.01 parts by weight, a problem in which the inherent effect of the white-white extract may not be exhibited, and when the content of the white-white extract exceeds 20 parts by weight, similar to the above case, " Since the problem of the fragrance of the finished product is too strong "," the problem that only raw materials are wasted without any additional effects ", etc. can be caused, in the present invention, in consideration of these problems, the content of sulfur white extract is mentioned above. It is appropriately maintained within one "0.01 to 20 parts by weight".

상술한 바와 같이, 버독추출물, 감초추출물, 황백추출물 등을 정제수 내에혼합시킨 상태에서, 본 발명에서는 각 구성물들의 혼합 균일도를 향상시키기 위하여, 앞의 정제수 용액을 임의의 교반기 내부에서 예컨대, 600rpm의 속도록 8분~12분간 교반(Agitation)하는 과정을 진행하며, 이후, 일정 시간이 경과하여, 상술한 혼합·교반 과정이 마무리되면, 버독추출물, 감초추출물, 황백추출물이 혼합된 정제수 용액은 일련의 제 1 혼합 중간체(First mixing intermediate)를 형성한다.As described above, in the state in which the bourdog extract, licorice extract, sulfur white extract and the like are mixed in the purified water, in the present invention, in order to improve the mixing uniformity of the respective components, the previous purified water solution in a stirrer, for example, 600 rpm After 8 minutes to 12 minutes of stirring (Agitation) process, and after a certain period of time, when the above-described mixing and stirring process is completed, purified water solution mixed with the bergok extract, licorice extract, yellow white extract To form a first mixing intermediate.

한편, 앞서 언급한 제 1 혼합 중간체의 형성과정과 독립적으로, 본 발명에서는 알코올 1 내지 50 중량부, 좀더 바람직하게, 5 내지 30 중량부에 살리실리산 0.001 내지 1 중량부, 좀더 바람직하게, 0.01 내지 0.5 중량부를 혼합하는 과정을 진행함으로써, 일련의 제 2 혼합 중간체를 형성시킨다.On the other hand, independent of the above-mentioned process of forming the first mixed intermediate, in the present invention 1 to 50 parts by weight of alcohol, more preferably 5 to 30 parts by weight of salicylic acid 0.001 to 1 parts by weight, more preferably, 0.01 By advancing the process to mix 0.5 parts by weight, a series of second mixing intermediates are formed.

이때, 살리실리산의 함량이 0.001 중량부 미만인 경우, 살리실리산 고유의 효과가 발휘되지 못하는 문제점이 야기될 수 있으며, 살리실시산의 함량이 1 중량부를 초과하는 경우, "피부에 불필요한 자극을 가하는 문제점"이 야기될 수 있기 때문에, 본 발명에서는 이러한 문제점을 충분히 감안하여, 살리실리산의 함량을 앞서 언급한 "0.001 내지 1 중량부" 내에서 적절히 유지시킨다.At this time, if the content of salicylic acid is less than 0.001 parts by weight, a problem that the intrinsic effect of salicylic acid may not be exhibited, and if the content of salicylic acid exceeds 1 part by weight, The problem to be added "can be caused, and in the present invention, in consideration of this problem, the content of salicylic acid is properly maintained within the aforementioned" 0.001 to 1 part by weight ".

또한, 알코올의 함량이 1 중량부 미만인 경우, "살리실리산을 적절하게 용해시킬 수 없는 문제점", "용해시키더라도, 불필요한 침전물을 발생시키는 문제점" 등이 야기될 수 있으며, 알코올의 함량이 50 중량부를 초과하는 경우, "피부에 불필요한 자극을 가하는 문제점"이 야기될 수 있기 때문에, 본 발명에서는 이러한 문제점을 충분히 감안하여, 알코올의 함량을 앞서 언급한 "1 내지 50 중량부" 내에서 적절히 유지시킨다.In addition, when the content of alcohol is less than 1 part by weight, "the problem of not being able to dissolve salicylic acid properly", "problem of generating an unnecessary precipitate even if dissolved", etc. can be caused, the content of alcohol is 50 When exceeding parts by weight, since "problem of applying unnecessary irritation to skin" can be caused, the present invention takes full account of these problems, so that the content of alcohol is properly maintained within the aforementioned "1 to 50 parts by weight". Let's do it.

다른 한편, 상술한 과정을 통해, 제 1 혼합 중간체 및 제 2 혼합 중간체의 형성이 모두 완료되면, 본 발명에서는 상술한 제 1·제 2 혼합 중간체를 서로 균일하게 섞으면서, 이 제 1·제 2 혼합 중간체를 예컨대, 75℃~85℃ 정도의 온도로 가열하는 과정을 진행한다.On the other hand, when the formation of the first mixed intermediate and the second mixed intermediate is completed through the above-described process, in the present invention, the first and second mixed intermediates described above are uniformly mixed with each other and the first and second mixed intermediates are formed. For example, the process of heating the mixed intermediate to a temperature of about 75 ~ 85 ℃.

이와 같은 가열과정이 진행될 때, 본 발명에서는 예컨대, 식물성 오일, 세토스테아릴 알콜(Setostearyl alcohol), 글리세롤 스테아레이트(Glycerol Stearate), 폴리옥시에틸렌(Polyoxyethylene), 스테아레이트(Stearate) 등과 같은 보습촉진제를 제 1·제 2 혼합 중간체에 더 부가함으로써, 최종 완성되는 여드름 치료용 조성물이 일련의 보습성을 장시간 유지할 수 있도록 한다.When such a heating process is performed, the present invention, for example, moisturizing accelerators such as vegetable oil, Setostearyl alcohol, Glycerol Stearate, Polyoxyethylene, Stearate, etc. By further adding to the first and second mixed intermediates, the finally completed composition for acne treatment can maintain a series of moisturizing properties for a long time.

이후, 상술한 가열과정이 모두 마무리되면, 본 발명에서는 혼합상태로 가열된 제 1·제 2 혼합 중간체를 예컨대, 35℃~45℃ 정도의 온도로 냉각시키고, 냉각이 완료된 제 1·제 2 혼합 중간체에 별도의 첨가물, 예컨대, 색소(Pigment), 방부제(Antiseptics), 향료(Perfume) 등을 더 부가·교반함으로써, 최종의 여드름 치료용 조성물을 제조·완료한다.Subsequently, when all the above-described heating processes are completed, in the present invention, the first and second mixed intermediates heated in the mixed state are cooled to, for example, a temperature of about 35 ° C to 45 ° C, and the first and second mixings in which the cooling is completed are completed. Additional additives such as pigments, antiseptics, perfumes, and the like are further added and stirred to the intermediate to prepare and complete the final acne treatment composition.

이하, 구체적인 실시예 및 비교예를 통해, 본 발명의 효과를 상세히 설명한다.Hereinafter, the effects of the present invention will be described in detail through specific examples and comparative examples.

먼저, 실시예 1에서는 아래의 <표 1>에 제시된 바와 같이, "정제수 10 중량부"에 "버독추출물 0.1 중량부, 감초추출물 0.1 중량부, 황백추출물 0.1 중량부"가 섞인 혼합물을 600rpm으로 10분간 교반하여, 일련의 제 1 혼합 중간체를 형성하고, 이와 별도로, 알코올 5 중량부에 살리실리산 0.1 중량부를 혼합하여, 일련의 제 2혼합 중간체를 형성한다.First, in Example 1, as shown in Table 1 below, "10 parts by weight of purified water" "0.1 parts by weight of Burdock extract, 0.1 parts by weight of licorice extract, 0.1 parts by weight of white and white extract" mixture at 600rpm 10 The mixture is stirred for a minute to form a series of first mixed intermediates, and separately, 0.1 parts by weight of salicylic acid is mixed with 5 parts by weight of alcohol to form a series of second mixed intermediates.

구분division 실시예1Example 1 실시예2Example 2 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 비교예4Comparative Example 4 구성물edifice 버독추출물 0.1 중량부0.1 parts by weight of Burdock extract 버독추출물 0.1 중량부0.1 parts by weight of Burdock extract 버독추출물 1 중량부1 part by weight of Burdock extract 감초추출물 0.1 중량부Licorice extract 0.1 parts by weight 감초추출물1 중량부Licorice Extract 1 part by weight 감초추출물 1 중량부Licorice extract 1 part by weight 황백추출물 0.1 중량부Yellow White Extract 0.1 parts by weight 황백추출물1 중량부Yellow White Extract 1 part by weight 황백추출물 1 중량부1 part by weight of yellow white extract 살리실리산 0.1 중량부0.1 parts by weight of salicylic acid 살리실리산1 중량부Salicylic Acid 1 part by weight 살리실리산 1 중량부1 part by weight of salicylic acid 정제수 10 중량부10 parts by weight of purified water 정제수 10 중량부10 parts by weight of purified water 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 알코올 5 중량부5 parts by weight of alcohol 알코올 5 중량부5 parts by weight of alcohol 동일량 첨가Equal amount 식물성오일 10 중량부10 parts by weight of vegetable oil 식물성오일 10 중량부10 parts by weight of vegetable oil 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 세토스테아릴알코올 2 중량부Cetostearyl alcohol 2 parts by weight 세토스테아릴 알코올 2 중량부Cetostearyl alcohol 2 parts by weight 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 글리세롤 스테아레이트 2 중량부2 parts by weight of glycerol stearate 글리세롤 스테아레이트 2 중량부2 parts by weight of glycerol stearate 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 폴리옥시에틸렌 100 중량부100 parts by weight of polyoxyethylene 폴리옥시에틸렌 100 중량부100 parts by weight of polyoxyethylene 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 스테아레이트 1 중량부1 part by weight of stearate 스테아레이트 1 중량부1 part by weight of stearate 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence 향료, 색소Spices 향료,색소Spices, pigments 동일량 첨가Equal amount 동일량첨가Equivalence 동일량첨가Equivalence 동일량첨가Equivalence

이어서, 기 형성된 제 1·제 2 혼합 중간체를 서로 균일하게 섞으면서, 80℃로 가열함과 아울러, 이 제 1·제 2 혼합 중간체에 식물성 오일 10 중량부, 세토스테아릴 알코올 2 중량부, 글리세롤 스테아레이트 2 중량부, 폴리옥시에틸렌 100 중량부, 스테아레이트 1 중량부를 더 부가한다.Subsequently, while heating the formed first and second mixed intermediates uniformly to each other at 80 ° C., 10 parts by weight of vegetable oil, 2 parts by weight of cetostearyl alcohol and glycerol were added to the first and second mixed intermediates. 2 parts by weight of stearate, 100 parts by weight of polyoxyethylene, and 1 part by weight of stearate are further added.

이후, 상술한 가열과정이 모두 마무리되면, 실시예 1에서는 기 가열된 제 1·제 2 혼합 중간체를 예컨대, 40℃로 냉각시키고, 냉각이 완료된 제 1·제 2 혼합 중간체에 색소, 향료 등을 더 부가·교반함으로써, 최종의 여드름 치료용 조성물을제조·완료한다.Subsequently, when the above-described heating process is completed, in Example 1, the preheated first and second mixed intermediates are cooled to, for example, 40 ° C., and pigments, perfumes, and the like are applied to the first and second mixed intermediates where cooling is completed. By further adding and stirring, a final acne treatment composition is produced and completed.

다음으로, 실시예 2에서는 "버독추출물의 함량이 1 중량부, 감초추출물의 함량이 1 중량부, 황백추출물의 함량이 1 중량부, 살리실리산의 함량이 1 중량부"인 것을 제외하고, 나머지 과정을 실시예 1과 동일하게 진행시켜, 최종의 여드름 치료용 조성물을 제조·완료한다.Next, in Example 2, except that "the content of Burdock extract is 1 part by weight, the licorice extract is 1 part by weight, the content of sulfur white extract is 1 part by weight, and the content of salicylic acid is 1 part by weight," The rest of the process is carried out in the same manner as in Example 1 to prepare and complete the final acne treatment composition.

한편, 앞의 <표 1>에 제시된 바와 같이, 비교예 1에서는 감초추출물, 황백추출물, 살리실리산의 혼합 없이, 단지, 버독추출물만을 1 중량부 혼합하는 것을 제외하고, 나머지 과정을 실시예 1과 동일하게 진행시켜, 최종의 여드름 치료용 조성물을 제조·완료한다.On the other hand, as shown in Table 1, in Comparative Example 1, without mixing licorice extract, yellowish white extract, salicylic acid, except for mixing only 1 part by weight of the Burdock extract, Example 1 Proceed in the same manner as described above to produce and complete the final acne treatment composition.

다음으로, 비교예 2에서는 버독추출물, 감초추출물, 황백추출물의 혼합없이, 단지, 살리실리산만을 1 중량부 혼합하는 것을 제외하고, 나머지 과정을 실시예 1과 동일하게 진행시켜, 최종의 여드름 치료용 조성물을 제조·완료한다.Next, in Comparative Example 2, except for mixing only 1 part by weight of only salicylic acid, without mixing the verdok extract, licorice extract, yellowish white extract, and the rest of the process in the same manner as in Example 1, the final acne treatment The composition for manufacture is manufactured and completed.

그 다음으로, 비교예 3에서는 버독추출물, 감초추출물, 살리실리산의 혼합없이, 단지, 황백추출물만을 1 중량부 혼합하는 것을 제외하고, 나머지 과정을 실시예 1과 동일하게 진행시켜, 최종의 여드름 치료용 조성물을 제조·완료한다.Next, in Comparative Example 3, except that 1 part by weight of only white and white extracts were mixed without mixing the verdock extract, licorice extract, and salicylic acid, the rest of the procedure was carried out in the same manner as in Example 1, and the final acne The therapeutic composition is prepared and completed.

그 다음으로, 비교예 4에서는 버독추출물, 황백추출물, 살리실리산의 혼합없이, 단지, 감초추출문만을 1 중량부 혼합하는 것을 제외하고, 나머지 과정을 실시예 1과 동일하게 진행시켜, 최종의 여드름 치료용 조성물을 제조·완료한다.Next, in Comparative Example 4, except that 1 part by weight of licorice extract was mixed without mixing the verdock extract, the yellowish white extract and salicylic acid, the rest of the procedure was carried out in the same manner as in Example 1, Prepare and complete the composition for acne treatment.

이하, 앞서 언급한 "실시예 1 및 실시예 2"와 "비교예 1 내지 비교예 4"를 통해 제조된 여드름 치료용 조성물의 테스트 결과를 토대로, 본 발명의 효과를 상세히 설명한다.Hereinafter, the effects of the present invention will be described in detail based on the test results of the acne treatment composition prepared through the aforementioned "Example 1 and Example 2" and "Comparative Examples 1 to 4".

구분division 실시예 1Example 1 실시예 2Example 2 최소저해농도Minimum inhibitory concentration 750ppm750 ppm 700ppm700 ppm

먼저, 본 출원인은 "실시예 1 및 실시예 2"를 통해 제조된 여드름 치료용 조성물을 적정 실험농도가 되도록, 제균(Microorganism elimination)·필터(Filtering)한 다음, 각 여드름 치료용 조성물에 "활성화시킨 여드름 피검균"을 1%씩 접종하고, 이 여드름 치료용 조성물을 37℃의 온도에서 48시간 혐기 배양한 후, 해당 여드름 피검균에 대한 각 여드름 치료용 조성물의 최소저해농도(MIC:Minimum Inhibitory Concentration)를 측정함으로써, 본 발명에 따른 여드름 치료용 조성물이 나타내는 "제균기능"을 평가하였다.First, the Applicant disinfects the microorganism elimination and filtering the composition for acne treatment prepared through "Examples 1 and 2" to an appropriate experimental concentration, and then "activates" each acne treatment composition. 1% of acne test bacteria, and the acne treatment composition was anaerobicly cultured at a temperature of 37 ° C. for 48 hours, and then the minimum inhibitory concentration (MIC: Minimum Inhibitory) of each acne treatment composition for the acne test bacterium. By measuring the concentration, the "bacterial function" of the acne treatment composition according to the present invention was evaluated.

그 결과, 위의 <표 2>에 제시된 바와 같이, 실시예 1 및 2를 통해 제조된 본 발명의 여드름 치료용 조성물은 각각 600ppm, 700ppm의 최소저해농도 값에서, "피검균의 성장을 억제시키는 결과"를 나타내었으며, 본 출원인은 "본 발명에 따른 여드름 치료용 조성물"이 우수한 "여드름균 제거기능"을 보유하고 있다는 사실을 확인하였다.As a result, as shown in Table 2 above, the compositions for acne treatment of the present invention prepared in Examples 1 and 2 are at the minimum inhibitory concentration values of 600 ppm and 700 ppm, respectively, Results ", the applicant confirmed that the" composition for acne treatment according to the present invention "has an excellent" acne bacteria removal function ".

그 다음에, 본 출원인은 일련의 여드름 치료효과 관찰과정을 진행하여, 본 발명을 통해 제조된 여드름 치료용 조성물의 여드름 완화 효과를 검증하였다.Next, the applicant proceeds a series of acne treatment effect observation process, and verified the acne relief effect of the acne treatment composition prepared through the present invention.

먼저, 본 출원인은 "15세~20세의 연령층"에 해당하는 20명의 여성들을 실험군으로 선택한 후, 이 실험군에 해당하는 여성들에게 실시예 2에 의해 제조된 여드름 치료용 조성물을 1일 2회 빈도로 4주 동안 도포하도록 하였다.First, the applicant selected 20 women corresponding to the "age group of 15 to 20 years" as the experimental group, and then the women for the experimental group frequency of the acne treatment composition prepared by Example 2 twice a day Application for 4 weeks.

구분division 실시예 2Example 2 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교에 33 in comparison 비교예 4Comparative Example 4 현저한 완화효과를 나타낸 사람수Number of people who showed significant mitigation effect 88 33 1One 00 00 완화효과가 있는 사람수The number of people with mitigation effect 1212 77 66 22 33 완화효과가 없는 사람수The number of people who do not have mitigation effect 00 1010 1212 1818 1717

이때, 본 출원인은 본 발명에 의해 제조된 여드름 치료용 조성물의 효과와 비교예에 의해 제조된 여드름 치료용 조성물의 효과를 정확히 비교하기 위하여, 각 실험군에 해당하는 여성들의 한쪽 볼에는 실시예 2에 의해 제조된 여드름 치료용 조성물을 도포하도록 하였으며, 다른 한쪽 볼에는 "비교예 1 내지 비교예 4"에 의해 제조된 여드름 치료용 조성물을 도포하도록 하였다.At this time, the Applicant is in Example 2 on one cheek of women corresponding to each experimental group in order to accurately compare the effect of the acne treatment composition prepared by the present invention and the effect of the acne treatment composition prepared by the Comparative Example It was made to apply the composition for acne treatment prepared by, and to the other ball was applied to the acne treatment composition prepared by "Comparative Example 1 to Comparative Example 4".

4주가 경과한 후, 본 출원인은 각 실험군에 해당하는 여성들의 여드름 완화 효과를 육안으로 관찰하여, 일련의 여드름 치료효과 검증과정을 완료하였다.After 4 weeks, Applicant visually observed the acne relief effect of women in each experimental group, and completed a series of acne treatment effect verification process.

이와 같은 측정과정 결과, 본 출원인은 앞의 <표 3>에 제시된 바와 같이, 본 발명의 실시예 2를 통해 제조된 여드름 치료용 조성물의 경우, 20명의 여성 모두에게 뚜렷한 여드름 완화 효과를 제공하고 있는데 반해, "비교예 1 내지 비교예 4"를 통해 제조된 각 여드름 치료용 조성물들의 경우, 단지, "10명, 7명, 2명, 3명"의 여성에게만 일련의 여드름 완화효과를 제공하고 있다는 것을 확인하였다.As a result of such a measurement process, the Applicant has provided a clear acne relief effect to all 20 women in the case of the acne treatment composition prepared through Example 2 of the present invention, as shown in Table 3 above. On the other hand, in the case of each acne treatment composition prepared through "Comparative Example 1 to Comparative Example 4", only a "10, 7, 2, 3" women provide a series of acne relief effect It was confirmed.

물론, 이러한 결과는 본 발명을 통해 제조된 여드름 치료용 조성물이 상술한, "피부염증 제거 기능", "여드름균 제거기능" 뿐만 아니라, "피부 이상각화 억제기능", "피지 과잉분비 억제기능" 까지도 한꺼번에 보유하고 있다는 사실을 반증하는 것이다.Of course, these results are not only "skin inflammation removal function", "acne bacteria removal function" described above, the acne treatment composition prepared through the present invention, "skin abnormality suppression function", "sebum oversecretion suppression function" It is a testament to the fact that it even holds it all at once.

이상에서, 상세히 설명한 바와 같이, 본 발명에서는 버독추출물, 감초추출물, 황백추출물, 살리실리산 등을 적정량 혼합하여, "염증/세균" 뿐만 아니라, 여드름 발생의 주요기전으로 밝혀진 다른 각 원인들까지도 개별적으로 대응·치료할 수 있는 복합 조성물을 구현한다.In the above, as described in detail, in the present invention, by mixing an appropriate amount of the Burdock extract, licorice extract, yellowish white extract, salicylic acid, etc., not only "inflammatory / bacterial", but also each of the other causes identified as the main mechanism of acne development It implements a composite composition that can respond to and treat.

이러한 본 발명이 달성되는 경우, 최종 완성되는 여드름 치료용 제품은 예컨대, "피부염증 제거 기능", "여드름균 제거기능" 뿐만 아니라, "피부 이상각화 억제기능", "피지 과잉분비 억제기능" 까지도 한꺼번에 보유할 수 있게 된다.When the present invention is achieved, the final acne treatment product is, for example, "skin inflammation removal", "acne bacteria removal", as well as "skin abnormal keratin suppression", "sebum oversecretion suppression" Can be held at once.

이러한 본 발명은 그 제형(Dosage form)에 특별히 구애됨이 없이, 다양한 여드름 치료용 제품, 예컨대, "여드름 치료용 크림제", "여드름 치료용 엣센스", "여드름 치료용 팩" 등에서 전반적으로 유용한 효과를 나타낸다.The present invention is generally useful in various acne treatment products, such as "acne cream", "acne treatment essence", "acne pack", and the like without particular limitation to the dosage form. Effect.

그리고, 본 발명의 특정한 실시예가 설명되고 도시되었지만 본 발명이 당업자에 의해 다양하게 변형되어 실시될 가능성이 있는 것은 자명한 일이다.And while certain embodiments of the invention have been described and illustrated, it will be apparent that the invention may be embodied in various modifications by those skilled in the art.

이와 같은 변형된 실시예들은 본 발명의 기술적사상이나 관점으로부터 개별적으로 이해되어서는 안되며 이와 같은 변형된 실시예들은 본 발명의 첨부된 특허청구의 범위안에 속한다 해야 할 것이다.Such modified embodiments should not be understood individually from the technical spirit or point of view of the present invention and such modified embodiments should fall within the scope of the appended claims of the present invention.

Claims (3)

소정의 유효성분이 함유된 허브추출물(Herbal extract) 0.01 내지 20 중량부, 감초추출물(Glycyrrhiza extract), 0.01 내지 20 중량부, 황백추출물(Phellodendron amurense extract), 0.01 내지 20 중량부 및 살리실리산(Salicylic acid) 0.001 내지 1 중량부가 서로 혼합되어 형성되는 것을 특징으로 하는 여드름 치료용 조성물.0.01 to 20 parts by weight of a herb extract (Herbal extract), a licorice extract (Glycyrrhiza extract), 0.01 to 20 parts by weight, Phellodendron amurense extract, 0.01 to 20 parts by weight and salicylic acid (Salicylic) acid) A composition for treating acne, characterized in that it is formed by mixing 0.001 to 1 parts by weight of each other. 제 1 항에 있어서, 상기 허브추출물은 버독추출물(Burdock extract)인 것을 특징으로 하는 여드름 치료용 조성물.According to claim 1, wherein the herbal extract is a composition for treating acne, characterized in that the Burdock extract (Burdock extract). 일정량의 정제수(Refined water)에 소정의 유효성분이 함유된 허브추출물 0.01 내지 20 중량부, 감초추출물 0.1 내지 20 중량부 및 황백추출물 0.1 내지 20 중량부를 혼합하여, 일련의 제 1 혼합 중간체(First mixing intermediate)를 형성함과 아울러, 1 내지 50 중량부의 알코올에 살리실리산 0.001 내지 1 중량부를 혼합하여, 일련의 제 2 혼합 중간체를 형성하고, 기 형성된 상기 제 1·제 2 혼합 중간체를 서로 균일하게 섞으면서, 일정 온도로 가열하는 단계와;A series of first mixing intermediates are mixed by mixing 0.01 to 20 parts by weight of a herb extract, 0.1 to 20 parts by weight of licorice extract and 0.1 to 20 parts by weight of sulfur white extract, in a predetermined amount of purified water. ), And from 1 to 50 parts by weight of alcohol are mixed with 0.001 to 1 parts by weight of salicylic acid to form a series of second mixed intermediates, and the previously formed first and second mixed intermediates are uniformly mixed with each other. And heating to a constant temperature; 혼합 상태로 가열된 상기 제 1·제 2 혼합 중간체를 일정 온도로 냉각하는 단계를 포함하는 것을 특징으로 하는 여드름 치료용 조성물 제조방법.And cooling the first and second mixed intermediates heated in a mixed state to a predetermined temperature.
KR1020010018830A 2001-03-27 2001-04-10 Composition for treating a acne vulgaris and method for fabricating the same KR20020078709A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020010018830A KR20020078709A (en) 2001-04-10 2001-04-10 Composition for treating a acne vulgaris and method for fabricating the same
PCT/KR2001/001740 WO2002076479A1 (en) 2001-03-27 2001-10-16 Composition for treating acne vulgaris and fabrication method
US10/473,044 US20040101577A1 (en) 2001-03-27 2001-10-16 Composition for treating acne vulgaris and fabrication method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010018830A KR20020078709A (en) 2001-04-10 2001-04-10 Composition for treating a acne vulgaris and method for fabricating the same

Publications (1)

Publication Number Publication Date
KR20020078709A true KR20020078709A (en) 2002-10-19

Family

ID=27700404

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010018830A KR20020078709A (en) 2001-03-27 2001-04-10 Composition for treating a acne vulgaris and method for fabricating the same

Country Status (1)

Country Link
KR (1) KR20020078709A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019107723A1 (en) * 2017-11-28 2019-06-06 주식회사 아모레퍼시픽 Composition for sebum control and pore minimizing
US20210346425A1 (en) * 2018-06-12 2021-11-11 The Trustees Of Columbia University In The City Of New York Botanical film-forming acne compositions
US11672753B2 (en) 2017-11-28 2023-06-13 Amorepacific Corporation Composition for sebum control and pore minimizing

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09255573A (en) * 1996-03-28 1997-09-30 Lion Corp Composition for treating acne
JPH10194914A (en) * 1997-01-08 1998-07-28 Shiseido Co Ltd Skin lotion
KR19990000085A (en) * 1997-06-02 1999-01-15 성재갑 Acne prevention and treatment composition containing extract
JPH11322630A (en) * 1998-05-08 1999-11-24 Nippon Zetokku Kk Antimicrobial agent, external preparation for skin and skin cleaning agent containing the same
KR20020065185A (en) * 2001-02-06 2002-08-13 퓨리메드 주식회사 The growth inhibition of Propionibacterium acnes for the multiple extracts of herbal medicaments

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09255573A (en) * 1996-03-28 1997-09-30 Lion Corp Composition for treating acne
JPH10194914A (en) * 1997-01-08 1998-07-28 Shiseido Co Ltd Skin lotion
KR19990000085A (en) * 1997-06-02 1999-01-15 성재갑 Acne prevention and treatment composition containing extract
JPH11322630A (en) * 1998-05-08 1999-11-24 Nippon Zetokku Kk Antimicrobial agent, external preparation for skin and skin cleaning agent containing the same
KR20020065185A (en) * 2001-02-06 2002-08-13 퓨리메드 주식회사 The growth inhibition of Propionibacterium acnes for the multiple extracts of herbal medicaments

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019107723A1 (en) * 2017-11-28 2019-06-06 주식회사 아모레퍼시픽 Composition for sebum control and pore minimizing
US11672753B2 (en) 2017-11-28 2023-06-13 Amorepacific Corporation Composition for sebum control and pore minimizing
US20210346425A1 (en) * 2018-06-12 2021-11-11 The Trustees Of Columbia University In The City Of New York Botanical film-forming acne compositions

Similar Documents

Publication Publication Date Title
Pundir et al. Ethnomedicinal uses, phytochemistry and dermatological effects of Hippophae rhamnoides L.: A review
KR101478945B1 (en) Shampoo composition containing native plant extracts and natural oriental material extracts
KR102017187B1 (en) Composition for preventing hair loss and promoting hair growth and manufacturing method thereof
KR101196523B1 (en) Composition for promoting hair growth comprising fermented oriental medicine extract
KR20130010885A (en) Composition containing extract of venus flytrap for cosmetic treatment
KR20130015339A (en) Cream composition for treating acne
JPS61291523A (en) Composition for treating acne
KR102049208B1 (en) Cosmetic composition for reducing acne and inhibiting sebum secretion
Satheeshan et al. Development and evaluation of VCO based herbal hair tonic
US20040101577A1 (en) Composition for treating acne vulgaris and fabrication method
KR102373929B1 (en) Cosmetics composition for scalp care in natural shampoo and essence comprising mixed ferment extracts of natural products
KR101332215B1 (en) Cosmetic composition containing fermentated complex of extracts with cryptomeria japonica and nelumbo nucifera for acne improvement and enhancing immune system
CN110652483A (en) Tea tree essential oil acne-removing cream
KR101397160B1 (en) Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance
CN112315883B (en) Skin care composition for controlling oil and removing acne and preparation and application thereof
CN114146014A (en) Compound menthyl nicotinate plant polysaccharide emulsifiable paste and preparation method thereof
KR20140145278A (en) Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect
KR20120003236A (en) Cosmetic composition containing broussonetia extract for improving acne
CN112472629A (en) Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof
KR102272771B1 (en) Cosmetic composition for alleviating sebum secretion comprising Carthamus tinctorius extract or mixture extract of Carthamus tinctorius and Areca catechu
KR102598348B1 (en) Composition for controlling sebum and reducing the skin pore
CN108938514B (en) Skin-clearing acne-removing liquid and preparation method thereof
KR20020078709A (en) Composition for treating a acne vulgaris and method for fabricating the same
KR101727475B1 (en) Method of producing a hair loss prevention and hair growth promoting composition of shampoo type
KR101938301B1 (en) Anti-acne composition comprising extracts of rubus coreanus, and willow or propolis

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application